Top Markets
Coin of the day
NovaBridge Biosciences NovaBridge Biosciences

NovaBridge Biosciences

NBP
Rang în acțiuni #18279
NovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering... NovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering immuno-oncology treatments for cancer patients within the United States. Its development pipeline features several significant drug candidates: givastomig, a bispecific antibody currently in Phase 1b clinical trials for gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, another bispecific antibody, which is undergoing Phase 1 clinical evaluation for solid tumors. The company maintains a strategic licensing agreement with Ferring International Center SA, encompassing the research, development, manufacturing, import, use, and commercialization rights for FE301, an interleukin-6 inhibitor. Additionally, NovaBridge Biosciences has established collaborations with Bristol Myers Squibb for givastomig's advancement, ABL Bio, Inc. for both givastomig and ragistomig, and TJ Bio for uliledlimab. Founded in 2014 and headquartered in Rockville, Maryland, the entity was formerly named I-Mab, with its transition to NovaBridge Biosciences slated for October 2025.
Preț acțiune
$1.79
Ultima sincronizare: 2026-09-02
Capitalizare de piață
$205.75M
Schimbare (1 zi)
3.18%
Schimbare (1 an)
-61.61%
Țară
US
Tranzacționează NovaBridge Biosciences (NBP)

Categorie

Istoricul spliturilor pentru NovaBridge Biosciences (NBP)
Acțiunea NovaBridge Biosciences (simbol: NBP) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Sep 03, 2026.
O acțiune NBP cumpărată înainte de Sep 03, 2026 este echivalentă astăzi cu 0 acțiuni NBP.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH